Oppo donates Rs 1 crore to PM relief fund | WeForNews | Latest News, Blogs Oppo donates Rs 1 crore to PM relief fund – WeForNews | Latest News, Blogs
Connect with us

Disaster

Oppo donates Rs 1 crore to PM relief fund

“We have initiated an Online Repair Service that will help you with basic troubleshooting and software related issues,”Athe company added.

Published

on

OPPO-smartphone

New Delhi, March 29 : Chinese manufacturer Oppo on Sunday said that it has donated Rs 1 crore to Prime Minister’s National Relief Fund and Uttar Pradesh Chief Minister’s Distress Fund to fight the novel coronavirus pandemic.

“It is a small step towards ensuring the well-being of those fighting at the frontline and showing our gratitude for the services they are providing to the citizens,” the company said in a statement.

The smartphone maker has also initiated an online repair service that will help with basic troubleshooting and software related issues.

“We have initiated an Online Repair Service that will help you with basic troubleshooting and software related issues,”Athe company added.

Meanwhile, the company has suspended all on-ground operations due to lockdown announced by the government and has also postponed the launch of OPPO Emco M31.

Disaster

NIMS begins subject registration for Covid 19 Vaccine clinical trial

Published

on

By

Covid 19 Vaccine

Hyderabad, July 7 : The subject enrolment for Phase-I clinical trial of India’s first indigenous vaccine for COVID-19 began at Nizam’s Institute of Medical Science (NIMS) here on Tuesday.

On the direction of the Indian Council of Medical Research (ICMR), authorities at NIMS began the process to register 30-60 subjects for the trial.

Blood and swab samples of the subjects will be collected and if found fit they will be administered the first dose of the vaccine after a week.

NIMS Director Dr K. Manohar told reporters that healthy subjects will be screened and their blood and swab samples sent to ICMR-designated lab in New Delhi. After receiving the test reports, the Department of Medicine will analyse the same and issue the fitness certificates to the subjects.

The subjects would be administered two doses of the vaccine. There will be two vaccine dosage of three micrograms and six micrograms, and a placebo.

Each subject would be given the second dose of the same vaccine after 14 days.

For two days after administering the vaccine, the subjects would be monitored for two days in the ICCU at NIMS by a team of doctors, after which they would be sent home and monitored through videoconference or phone.

The phase-I clinical trial would go on for 28 days, after which the ICMR and the Drug Controller General of India (DGCI) would accord permission for Phase-II trial with more subjects.

Phase-1 would have around 375 subjects across the country and Phase-II 875.

NIMS is one of the hospitals selected by the ICMR to undertake clinical trials of Covaxin, which it is developing in partnership with Hyderabad-based Bharat Biotech International Limited (BBIL).

Meanwhile, the Ethics Committee at King George Hospital (KGH) in Visakhapatnam will hold a crucial meeting on Tuesday to finalise the preparations for the clinical trials. KGH is also one of the hospitals selected by ICMR for the trials.

In a letter to the heads of the selected institutions last week, ICMR Director General Balram Bhargava asked them to fast-track all approvals related to initiation of the clinical trials and ensure that the subject enrollment is initiated no later than July 7.

“It is envisaged to launch the vaccine for public health use latest by August 15, 2020 after completion of all clinical trials. BBIL is working expeditiously to meet the target; however, the final outcome will depend on the cooperation of all clinical trial sites involved in this project,” reads the letter dated July 2.

He noted that this is the first indigenous vaccine being developed by India and is one of the top priority projects that is being monitored at the topmost level of the government.

“The vaccine is being derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine,” he wrote.

While experts raised doubts on the August 15 target, the ICMR defended it, saying its process is in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential.

The research body said the Director’s letter was intended to cut red tape, without bypassing any necessary process, and speed up recruitment of participants for human trials so that these phases can be completed at the earliest.

BBIL refused to comment on ICMR’s August 15 deadline.

The company had announced on June 29 that it had successfully developed Covaxin, India’s first vaccine candidate for COVID-19, in collaboration with the ICMR and NIV.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine has been developed and manufactured in Bharat Biotech’s BSL-3(Bio-Safety Level 3) High Containment Facility located in Genome Valley, Hyderabad, the company said.

The Drug Controller General of India – Central Drugs Standard Control Organization (CDSCO), Ministry of Health & Family Welfare granted permission to initiate Phase I and II human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

Continue Reading

Disaster

52 killed in Japan due to torrential rain

In Omuta, about 200 people were left stranded at two evacuation centres after floodwaters surged in the area.

Published

on

Japan Rain Flood

Tokyo, July 7 : The death toll due to the torrential rain in Japan’s Kyushu region increased to 52 on Tuesday, with the government issuing its highest alert as the Chikugo river in Oita prefecture overflowed.

Kumamoto prefecture registered the highest number of victims at 51, while 11 people were reported missing, The Japan Times quoted authorities as saying.

The 52nd victim, a woman in Omuta Fukuoka prefecture, was found at her submerged home on Monday night and was confirmed dead Tuesday at a hospital.

In Omuta, about 200 people were left stranded at two evacuation centres after floodwaters surged in the area.

The Chikugo River, the largest in the Kyushu region, overflowed in Hita, Oita prefecture, prompting a local meteorological observatory and the land ministry to issue the highest-level alert to residents on Tuesday morning.

The death toll from the heavy rains that started in the early hours of July 4 is expected to climb as search efforts for the missing continued at sites hit by landslides and floods.

Continue Reading

Disaster

UN urges international community to unite against terroism amid pandemic

The Secretary-General urged member states to keep the momentum in the fight against terrorism and be innovative in their responses, which must protect and promote human rights.

Published

on

By

Antonio Guterres

United Nations, July 7 : A week-long UN Virtual Counter-Terrorism Week has kicked off to discuss the strategic and practical challenges of countering terrorism in a global pandemic environment.

Speaking at the high-level opening session on Monday, UN Secretary-General Antonio Guterres said: “Like the virus, terrorism does not respect national borders. It affects all nations and can only be defeated collectively.

“So, we must harness the power of multilateralism to find practical solutions.”

The UN chief warned that “IS, Al Qaeda, their regional affiliates – as well as neo-Nazis, white supremacists and other hate groups – seek to exploit divisions, local conflicts, governance failures and grievances to advance their objectives”, reports Xinhua news agency

The Secretary-General urged member states to keep the momentum in the fight against terrorism and be innovative in their responses, which must protect and promote human rights.

“We must commit to do more and better. As in every other area of our mission. Our work should be assessed by the difference we make in people”s lives,” he stressed.

The Virtual Counter-Terrorism Week encompasses a total of 10 webinars and interactive discussions, in which more than 1,000 representatives will address key counter-terrorism topics in light of the COVID-19 crisis across all four pillars of the UN Global Counter-Terrorism Strategy.

Continue Reading
Advertisement

Most Popular